DNA As Drug Targets Flashcards
Oswald Avery
Franklin
Watson Crick
DNA is main constituent of genes
First Xray picture of DNA
DNA Structure
RNA
- Phospho linked polymer of phosphoribose glycosides
- Has the second -OH group

Purine:
Adenine
Has 1 HB acceptor / 1 HB donor

small Arrow shows RIBOSE or DEoxyribose Attachment
Guanine
(purine)
2 HB Donor’s /1 HB Acceptor
small Arrow shows RIBOSE or DEoxyribose Attachment

Pyrimidine:
Cytosine
2 HB Acceptors / 1 HB Donor
Small arrow shows only DEOXYRIBOSE Attachment

Thymine / Uracil
Pyrimadine
1 HB acceptor / 1 HB Donor
Small arrow shows only DEOXYRIBOSE Attachment

DNA
Details
- NONREDUCING polyglycoside
- DOES NOT exist in equiibruim with an OPEN chain sugar
- Depurination process (from drugs / diseases)
- –> result in equilibrium
- –> DNA STRAND SCISSION
- –> result in equilibrium
Why is RNA not a reliable storage medium?
- Typically for DNA, Phosphodiester bond is EXTERMELY resistant to Hydroysis
- half life ~12million years
-
RNA is 1000x faster
- due to the presence of the 2’-OH group in RNA
- poised for attack on the phosphorus of 3’ phosphodiester
- due to the presence of the 2’-OH group in RNA
Structure of Nucleotides
- Nucleotides have B-configuration of the Glycosidic Bond
-
PUCKERED
- determined by what is bound to the ring
- destablizing eclipsing steric interactions of substituents on adjacent carbon atom
- = TORSION STRAIN
*
- = TORSION STRAIN
Canonical B-Dna
- C2-endo sugar puckers
- HIGH anti-glycosidic angles
- 3.4Angstrom helical rise per residue
- Right Handed (10 base pairs per turn)
- <15 degree bending
A Form DNA
- C3’s endo puckers
- Anti glycosidic angle
- Base pairs TWISTED
- small helix rise
- 11 bp per repeat
- Distinction between MINOR & MAJOR
- Major groove = DEEP & Narrow
- Minor grove = WIDE & SHALLOW
- Larger diameter
Z-Form DNA
- LEFT HANDED HELIX
- GC-Rich sequences
- Narrower / most elongated
- Grooves are NOT well defined
-
Favored by HIGH SALT conc
- some base subs
- Needs alternating purine/pyrimidine sequence
Classes of DNA Interactive Drugs
-
Reversible Binders
- reversible DNA interactions
-
Alkylators
- react COVALENTLY w/ DNA bases
-
Strand Breakers
- generate REACTIVE RADICALS that CLEAVE polynucelotide strands
Cancer Cells
- Constantly need DNA & precursers
-
Selective Toxicity
- Rapid uptake of drug molecules
- repair mechanisms are too slow
- activation of proteins such as P53 in normal cells
- –> response to DNA damage
- ^dna repair enzymes
- Cell cycle arrest (time to repair)
- apoptosis
- –> response to DNA damage
Combination Chemotherapy
- Compared to a SINGLE drug
- Able to fight AQUIRED resistance
- Different MOA’s –> increased effectiveness
- Covalent modifcations can be REVERSED by repair enzymes
- Inhibitors of DNA repair can be added
Major Groove
Deep & Wide (24Angs)
rich in Basic Atoms
36A x 20A
- DNA ligands have high specificity to WHICH GROOVE they bind
- typically poor sequence speficity
- more specific on which groove
Minor Groove
Deep and NARROW (20Angs)
lined w/ HYDROPHOBIC H-atoms of ribose
- 4A x 20A
* Small Molecules (<1000D) bind in minor groove
3 Ways to Reversibly Bind to Duplex DNA
-
External Electrostatic
- Backbone = Negatively charged (due to phosphodiester groups)
- –> Charge Interactions w/ charged groups
- EX. NH3+ ——- (-)phosphodiester groups
- Groove Binder
-
Intercalation
-
Planar groups slide INBETWEEN
- VDW interactions + Pi Pi stacking
-
Planar groups slide INBETWEEN
Cis-Platinum
(anti-neoplastic)
Covalent = IRREVERSIBLE
Anti-cancer
- Way that SMALL molecule can bind to DNA
- Very Stable
3 Ways small molecules can bind to DNA
Covalent - Irreversible
cis-plat
Minor Groove Bider
netropsin
Intercalator
dynemyci
Netropsin
Minor Groove Binder
Peptide analog Antibiotic (+/- Bacteria)
- Small molecule that binds to DNA
- 4 consecutive bases = H-bonding
- Displaces WATER
Dynemycin
DNA Intercalator
Enediyne Anticancer Drug
- small molecule that binds to DNA duplex
- Planar Pi Pi Binding
Major Groove Dna BInders
- Some might just BIND, –> small or NO EFFECT on structure
- C2-Repressor
- Some may cause Major Distortions
- TATA Binding Protein
- Spermine
- binds to DNA by electrostatic forces
Methylproamine
Minor Groove Binder
Radioprotector / DNA STAIN
- planar but CURVED to fit in minor groove
Minor groove binders
- long / planar / crescent(bent) shaped molecules
-
hydroPHOBIC
- but w/ HB capability to form HB’s w’ DNA bases
- Most bind to AT-Rich sequences (are where minor groove is NARROWER)
- AntiMicrobial / AntiTumor activities
- BOTH Reversible & Irreversable
- Reversible –> prevent access of cell proteins to DNA
- irreversable dmg – > alkylation of bases
Platinum Based Anti-neoplastics
Structures & Types
Cis-platin / Carboplatin / Oxaliplatin / Phenatriplatin

Platinum Anti-neoplastics
MOA
-
Covalent Binding –> dGpG-N7 NITROGENS
- form intra-strand crosslink
- bond to platimum cannot be too LABILE = Toxic
- nor too strong = low activity
- Bridges the two bases –> DISTORTION in DNA
- inhibition of Transcription
- RNA Polymerase STALLS –> Apoptosis
- typically carbon –> TETRAHYDRAL
*
Phenanthriplatin
7-40 Times MORE POTANT than Cis-Platin
- result of better Transport & possible intercalation of drug
- Steven Lippard still develiping the drug for human cancer
DNA Alkylators
Examples & Structures
Carmustine (BCNU) / Cyclophosphamide / Melphalan
2x -Chlorine

DNA Alkylators
- Target DNA by ALKYLATING the DNA Bases
- Common: Alkylation of GUANINE N-7 (most preferred >N-3 of adenine)
- generates POSITIVE charge @ nitrogen
- –> profound hydrolytic instability of glycosidic bond
- –> DEPURINation & DNA strand SCISSION
-
Bifunctional Alkylators –> DNA-crosslinking
- Two bonds on sense / anti-sense
- Makes them unable to be transcribed
- due to the COVALENT bond
- NONSELECTIVE = TOXIC
Order of NUCLEOPHILICITY
of DNA sites in ALKYLATION RXNS
N-7 of guanine > N-3 of adenine
> N-7 of adenine > N-3 of guanine > N-1 of adenine > N-1 of cytosine
*N-3 of cytosine / O-6 of guanine & phosphate groups can also be alkylated

MOA of Alkylating Drugs
- Nitrogen Nucleophilicity CRITICAL
- Unsubstituated mustards = too reactive / toxic
-
EWG substituants (linked to the nitrogen, R group)
- –> LOWER nucleophlicity/reactivity

Negatives of DNA Alkalators
- Can result in MUTATIONS
- –> lead to secondary cancer
- after the remission
-
Modification can lead to DNA DEPURINation (abasic sites)
- and/or Strand scission
- –> trigger DNA repair
- if attack is too massive, DNA repair can not cope with it.
- and/or Strand scission
All DNA modifying agents are…
Electrophiles
form covalent adducts w/ DNA nuceleophilic sites (bases/phosphodiester groups)
DNA Strand Scission by Alkylating Drugs
MOA
- Positive charge on N –> Glycoside break up
- –> Ribose Hemiacetal (in EQ w/ open chain)
- –> Open Chain Ribose
-
Beta-Elimination
- strand scission w/ the Phosphate group

DNA Supercoiling
Topoisomerases
RELIEVES POSITIVE TWISTING
- Topoisomerase catalyzes the transition of the topological forms of DNA
-
Critical Step = formation of covalent-cleavable complex
- Attack of active site TYROSINE -OH group on P-group of DNA chain
- P-O bond Scission
- Dna has to be RELIGATED to liberate the tyrosine
- Attack of active site TYROSINE -OH group on P-group of DNA chain
- *if this step does not occur
- topo is IRREVERSIBLY INACTIVATED
Actinomycin
DNA Intercalator
Antitumor agent
rhabdomyosarcoma and trophoblastic neoplasia
- Derived from Streptomyces
-
Stabalizes cleavable complex of topoisomerases
-
Cyclic pentapeptide –> aromatic Chromophore
- via amide bonds (numerous H-bonds)
-
Cyclic pentapeptide –> aromatic Chromophore

Topotecan-Resistant Topoisomerase 1
- Intercalator comes in and SPLITS the 2 bases
-
Topo Inhibitor prevents the intercalator from releasing
- –> keeps the Nucleic acid from re-joining together
-
Disruption of Topo Catalysis w/ topotecan
-
–> stabilization of DNA-Topo adduct
- & DNA lesion
-
–> stabilization of DNA-Topo adduct
Topo Inhibitors as Drugs
- Topo inhibitors = DNA Intercalators
- But intercalation is NOT sufficient for TOPO inhibitor
-
must also STABILIZE the cleavable topo-dna complex
- where DNA is covalently linked to TOP-TYR residue
- Cleavable complex cannot be religated
-
due to conformational change imposed on TOPO by inhibitor
- –> DNA strand breaks that CANNOT be repaired by DNA ligase
-
due to conformational change imposed on TOPO by inhibitor
Doxorubicin
Daunorubicin
Idarubicin
Anthracyclin Antibiotics (contain CHROMATIN)
Topoisomerase Inhibitors
- Common anticancer drugs –>
- Leukemia / Hodkins Lymphoma / Bladder/breast/lung cancer
- __Limiting factor –> Adverse heart effects
- related to formation of ROS (reactive oxygen species)
- Antracyclin residue undergoes redox processes
- –> generation of -OH radical
- –> can cleave DNA strand
- –> generation of -OH radical

Camptothecin
Topotecan
DNA Intercalaters that are ALSO TOPO-Inhibitors
in principle MOST DNA intercalators are CARCINOGENS
Duocarmycins
Minor Groove Binder
activated by conformational change after binding to minor groove
Mitomycin
Target DNA
Activated by metabolic reduction
Dacarbazine
Target DNA
activated by P450 hydroxylation
Leinamycin
Drug that targets DNA
Activated metobolically by reactions with THIOLS
Anthracyclins:
Rubicins / Bleomycin / Enidyns antitumor AB’s
Hydroxyl Radical Forming drugs
Based from DNA-based radicals
cause DNA Scission / Lesions
Thymidylate Synthase Inhibitors
RT inhibitors
Modulators of Epigenic control of DNA Replication
Target DNA
Affect DNA SYNTHESIS
Antisense Drugs
- Synthetic nuclease-reisistant oligomers of DNA
- form stable duplexes w/ RNA
- –> inhibit TRANSLATION of any specific gene
-
in principle can be made to treat any disease resulting from gene overexpression
- by using a proper sequence of nucleobases
-
in principle can be made to treat any disease resulting from gene overexpression
-
4 drugs have been approved by FDA
-
Etlepirsen (2016)
- –> treatment of Duchenne muscular dystrophy
-
Etlepirsen (2016)
- __Challenges:
- Drug delivery (high neg charge / MW )
- very high cost
*
Antisense Nucleotides
- Requirements for an effective antisense oligonucleotide:
- Form Stable Duplex w/ native DNA/RNA
- Resist Action of Nucleases
-
Modifications to DNA structure:
- phosphorothiorate analog
- protection of 2’-OH group of ribose
- replacement of ribose by morpholino residue
- removal of negative charge
How platin adducts affect DNA fxn?
DNA Adduct = segment of DNA bound to cancer causing chemical
Covalently bind to N7 nitrogens –> Intrastrand crosslink
crosslink –> INHIBIT TRANSCRIPTION
–> APOPTOSIS
Mono vs BI-functional
DNA Alkylators
-
MONO-functional = alkylation –> positive charge on nitrogen
-
profound hydrolytic instability
- –>depurination –> DNA Strand Scission
- Bi-Functional = TWO bonds on sense and anti-sense
- Cross-links the two bonds, makes them unable to be trascribed
- Due to the covalant bond
-
profound hydrolytic instability
Cyclophosphamide
DNA Alkylating Drug
-
Has a NON-NUCLEOPHILIC NITROGEN
- needs to be metabolicly activated in order to render the Nitrogen nucleophilic
- = PRODRUG

Topoisomerase
- RELIEVE the supercoiling of DNA so that replication could occur
-
Inhibiting TOPO
- stabilizes the cleavable complex between DNA / TOP
- –> prevent re-ligation of the excised DNA fragments
- = anti-cancer drug
- stabilizes the cleavable complex between DNA / TOP
- TOPOs cut DNA strands as part of their catalytic mechanism of relaxation of DNA superhelical state.